Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP648695.RAKw4ZY1ZQfeayvGnvPP5vCF8YvHUqT6FQCKEvpIrcQM4130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP648695.RAKw4ZY1ZQfeayvGnvPP5vCF8YvHUqT6FQCKEvpIrcQM4130_assertion type Assertion NP648695.RAKw4ZY1ZQfeayvGnvPP5vCF8YvHUqT6FQCKEvpIrcQM4130_head.
- NP648695.RAKw4ZY1ZQfeayvGnvPP5vCF8YvHUqT6FQCKEvpIrcQM4130_assertion description "[Prostate cancer patients carrying AA genotype or at least one A allele of CCR2 V64I had significantly increased risk for high stage disease (p=0.002 and p=0.039, respectively) and metastasis (p=0.004 and p=0.022, respectively).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP648695.RAKw4ZY1ZQfeayvGnvPP5vCF8YvHUqT6FQCKEvpIrcQM4130_provenance.
- NP648695.RAKw4ZY1ZQfeayvGnvPP5vCF8YvHUqT6FQCKEvpIrcQM4130_assertion evidence source_evidence_literature NP648695.RAKw4ZY1ZQfeayvGnvPP5vCF8YvHUqT6FQCKEvpIrcQM4130_provenance.
- NP648695.RAKw4ZY1ZQfeayvGnvPP5vCF8YvHUqT6FQCKEvpIrcQM4130_assertion SIO_000772 22612293 NP648695.RAKw4ZY1ZQfeayvGnvPP5vCF8YvHUqT6FQCKEvpIrcQM4130_provenance.
- NP648695.RAKw4ZY1ZQfeayvGnvPP5vCF8YvHUqT6FQCKEvpIrcQM4130_assertion wasDerivedFrom befree-20140225 NP648695.RAKw4ZY1ZQfeayvGnvPP5vCF8YvHUqT6FQCKEvpIrcQM4130_provenance.
- NP648695.RAKw4ZY1ZQfeayvGnvPP5vCF8YvHUqT6FQCKEvpIrcQM4130_assertion wasGeneratedBy ECO_0000203 NP648695.RAKw4ZY1ZQfeayvGnvPP5vCF8YvHUqT6FQCKEvpIrcQM4130_provenance.